The Platelet Storage Lesion

Clinics in Laboratory Medicine

Volumn 30, Issue 2, 2010, Pages 475-487

  Devine, Dana V ^a,b   Serrano, Katherine ^a,b  

^a CANADIAN BLOOD SERVICES   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Platelet concentrates; Platelet storage lesion; Platelet transfusion

Indexed keywords

BACTERIAL TOXIN; THROMBOCYTE CONCENTRATE;

BACTERIUM CONTAMINATION; BLOOD BANK; BLOOD DONOR; CELL SHAPE; CELL SURVIVAL; CELL VIABILITY; DISEASE TRANSMISSION; DONOR SELECTION; GOLD STANDARD; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TEMPERATURE; INFECTION RISK; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROCESS TECHNOLOGY; QUALITY CONTROL; REVIEW; SAFETY; SHELF LIFE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE LIFESPAN; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPOIESIS;

BLOOD PLATELETS; BLOOD PRESERVATION; CELL SURVIVAL; HUMANS; PLATELET TRANSFUSION; TEMPERATURE;

EID: 77953331685     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2010.02.002     Document Type: Review

References (64)

1. Dillard J.H., Brecher G., Cronkite E.P. Separation, concentration, and transfusion of platelets. Proc Soc Exp Biol Med 1951, 78(3):796-799.
2. Murphy S., Gardner F.H. Effect of storage temperature on maintenance of platelet viability-deleterious effect of refrigerated storage. N Engl J Med 1969, 280(20):1094-1098.
3. Lee J-H. Bacterial Contamination of Platelets Workshop. U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research. Bethesda (MD), September 24, 1999. p. 70-83.
4. Blajchman M.A., Beckers E.A.M., Dickmeiss E., et al. Bacterial detection of platelets: current problems and possible resolutions. Transfus Med Rev 2005, 19(4):259-272.
5. Murphy S., Gardner F.H. Platelet storage at 22 degrees C; metabolic, morphologic, and functional studies. J Clin Invest 1971, 50(4):370-377.
6. Simon T.L. The collection of platelets by apheresis procedures. Transfus Med Rev 1994, 8(2):132-145.
7. Sweeney J.D., Holme S., Heaton W.A., et al. White cell-reduced platelet concentrates prepared by in-line filtration of platelet-rich plasma. Transfusion 1995, 35(2):131-136.
8. Murphy S. Platelets from pooled buffy coats: an update. Transfusion 2005, 45(4):634-639.
9. Vassallo R.R., Murphy S. A critical comparison of platelet preparation methods. Curr Opin Hematol 2006, 13(5):323-330.
10. Levin E., Culibrk B., Gyongyossy-Issa M.I., et al. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production. Transfusion 2008, 48(11):2331-2337.
11. Pietersz R.N., Engelfriet C.P., Reesink H.W., et al. Evaluation of stored platelets. Vox Sang 2004, 86(3):203-223.
12. Divers S.G., Kannan K., Stewart R.M., et al. Quantitation of CD62, soluble CD62, and lysosome-associated membrane proteins 1 and 2 for evaluation of the quality of stored platelet concentrates. Transfusion 1995, 35(4):292-297.
13. Kannan K., Divers S.G., Lurie A.A., et al. Cell surface expression of lysosome-associated membrane protein-2 (lamp2) and CD63 as markers of in vivo platelet activation in malignancy. Eur J Haematol 1995, 55(3):145-151.
14. Kaplan K.L., Owen J. Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vitro. Blood 1981, 57(2):199-202.
15. Kunicki T.J., Tuccelli M., Becker G.A., et al. A study of variables affecting the quality of platelets stored at " room temperature" Transfusion 1975, 15(5):414-421.
16. Kim B.K., Baldini M.G. The platelet response to hypotonic shock. Its value as an indicator of platelet viability after storage. Transfusion 1974, 14(2):130-138.
17. Holme S., Murphy S. Quantitative measurements of platelet shape by light transmission studies; application to storage of platelets for transfusion. J Lab Clin Med 1978, 92(1):53-64.
18. Murphy S., Sayar S.N., Gardner F.H. Storage of platelet concentrates at 22°C. Blood 1970, 35(4):549-557.
19. Li J., Xia Y., Bertino A.M., et al. The mechanism of apoptosis in human platelets during storage. Transfusion 2000, 40(11):1320-1329.
20. Maurer-Spurej E., Labrie A., Pittendreigh C., et al. Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies. Transfusion 2009, 49(11):2276-2284.
21. Maurer-Spurej E., Brown K., Labrie A., et al. Portable dynamic light scattering instrument and method for the measurement of blood platelet suspensions. Phys Med Biol 2006, 51(15):3747-3758.
22. Guide to the preparation, use, and quality assurance of blood components 2007, Council of Europe Publishing, Strasbourg (France). 13th edition.
23. Mathai J., Resmi K.R., Sulochana P.V., et al. Suitability of measurement of swirling as a marker of platelet shape change in concentrates stored for transfusion. Platelets 2006, 17(6):393-396.
24. Bertolini F., Agazzi A., Peccatori F., et al. The absence of swirling in platelet concentrates is highly predictive of poor posttransfusion platelet count increments and increased risk of a transfusion reaction. Transfusion 2000, 40(1):121-122.
25. Holme S., Heaton A., Roodt J. Concurrent label method with 111In and 51Cr allows accurate evaluation of platelet viability of stored platelet concentrates. Br J Haematol 1993, 84(4):717-723.
26. Murphy S., Rebulla P., Bertolini F., et al. In vitro assessment of the quality of stored platelet concentrates. Transfus Med Rev 1994, 8(1):29-36.
27. Goodrich R.P., Li J., Pieters H., et al. Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects. Vox Sang 2006, 90:279-285.
28. Murphy S., Kahn R.A., Holme S., et al. Improved storage of platelets for transfusion in a new container. Blood 1982, 60(1):194-200.
29. Holme S., Heaton W.A., Courtright M. Improved in vivo and in vitro viability of platelet concentrates stored for seven days in a platelet additive solution. Br J Haematol 1987, 66(2):233-238.
30. Heaton W.A.L., Holme S., Keegan T. Development of a combined storage medium for 7-day storage of platelet concentrates. Br J Haematol 1990, 75(3):400-407.
31. Moroff G., Holme S., George V.M., et al. Effect on platelet properties of exposure to temperatures below 20°C for short periods during storage at 20 to 24°C. Transfusion 1994, 34(4):317-321.
32. Holme S., Sweeney J.D., Sawyer S., et al. The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability. Transfusion 1997, 37(1):12-17.
33. Rinder H.M., Murphy M., Mitchell J.G., et al. Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion 1991, 31(5):409-414.
34. Triulzi D.J., Kickler T.S., Braine H.G. Detection and significance of alpha granule membrane protein 140 expression on platelets collected by apheresis. Transfusion 1992, 32(6):529-533.
35. Dumont L.J., AuBuchon J.P., Whitley P., et al. Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study. Transfusion 2002, 42(7):847-854.
36. Holme S., Bode A., Heaton W.A., et al. Improved maintenance of platelet in vivo viability during storage when using a synthetic medium with inhibitors. J Lab Clin Med 1992, 119(2):144-150.
37. Hoffmeister K.M., Felbinger T.W., Falet H., et al. The clearance mechanism of chilled blood platelets. Cell 2003, 112(1):87-97.
38. Michelson A.D., Barnard M.R., Hechtman H.B., et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A 1996, 93(21):11877-11882.
39. Holme S. In vitro assays used in the evaluation of the quality of stored platelets: correlation with in vivo assays. Transfus Apheresis Sci 2008, 39:161-165.
40. Arnold D.M., Heddle N.M., Kulczycky M., et al. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers. Transfusion 2006, 46(2):257-264.
41. Holme S. Storage and quality assessment of platelets. Vox Sang 1998, 74(Suppl 2):207-216.
42. Rinder H.M., Snyder E.L., Tracey J.B., et al. Reversibility of severe metabolic stress in stored platelets after in vitro plasma rescue or in vivo transfusion: restoration of secretory function and maintenance of platelet survival. Transfusion 2003, 43:1230-1237.
43. Mondoro T.H., Shafer B.C., Vostal J.G. Restoration of in vitro responses in platelets stored in plasma. Am J Clin Pathol 1999, 111(5):693-699.
44. Mintz P.D., Anderson G., Avery N., et al. Assessment of the correlation of platelet morphology with in vivo recovery and survival. Transfusion 2005, 45(Suppl 2):72S-80S.
45. Snyder E.L., Moroff G., Heaton S.A. Recommended methods for conducting radiolabeled platelet survival studies. Transfusion 1986, 26(1):37-42.
46. Heddle N.M., Arnold D.M., Boye D., et al. Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review. Transfusion 2008, 48(7):1447-1458.
47. Pereira A., Sanz C. Effect of extending the platelet storage time on platelet utilization: predictions from a mathematical model of prophylactic platelet support. Transfus Med 2007, 17(2):119-127.
48. Bradley A.J., Read B.L., Levin E., et al. Small-molecule complement inhibitors cannot prevent the development of the platelet storage lesion. Transfusion 2008, 48(4):706-714.
49. Fijnheer R., Modderman P.W., Veldman H., et al. Detection of platelet activation with monoclonal antibodies and flow cytometry. Changes during platelet storage. Transfusion 1990, 30(1):20-25.
50. Thon J.N., Devine D.V. Translation of glycoprotein IIIa in stored blood platelets. Transfusion 2007, 47(12):2260-2270.
51. Thiele T., Steil L., Gebhard S., et al. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007, 47(7):1221-1233.
52. Thon J.N., Schubert P., Duguay M., et al. Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches. Transfusion 2008, 48(3):425-435.
53. Schubert P., Devine D.V. Proteomics meets blood banking: Identification of protein targets for the improvement of platelet quality. J Proteomics 2010, 73(3):436-444.
54. van der Meer P.F. Platelet additive solutions: a future perspective. Transfus Clin Biol 2007, 14(6):522-525.
55. Blajchman M.A. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation. Transfus Clin Biol 2009, 16(2):70-74.
56. van der Meer P.F., Pietersz R.N.I., Reesink H.W. Storage of platelets in additive solution for up to 12 days with maintenance of good in-vitro quality. Transfusion 2004, 44(8):1204-1211.
57. Diedrich B., Ringden O., Watz E., et al. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients. Vox Sang 2009, 97(3):254-259.
58. Diedrich B., Sandgren P., Jansson B., et al. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution. Vox Sang 2008, 94(2):96-102.
59. Zhang J.G., Carter C.J., Culibrk B., et al. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma. Transfusion 2008, 48(5):847-856.
60. Lin L., Cook D.N., Wiesehahn G.P., et al. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 1997, 37(4):423-435.
61. Ruane P.H., Edrich R., Gampp D., et al. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004, 44(6):877-885.
62. Mohr H., Gravemann U., Bayer A., et al. Sterilization of platelet concentrates at production scale by irradiation with short-wave ultraviolet light. Transfusion 2009, 49(9):1956-1963.
63. McCullough J., Vesole D.H., Benjamin R.J., et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 2004, 104(5):1534-1541.
64. AuBuchon J.P., Herschel L., Roger L., et al. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion 2005, 45(8):1335-1341.